- Home
- WRAP vs CTSO Comparison
WRAP vs CTSO Comparison
Compare WRAP & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRAP
- CTSO
- Stock Information
- Founded
- WRAP 2016
- CTSO 1997
- Country
- WRAP United States
- CTSO United States
- Employees
- WRAP N/A
- CTSO N/A
- Industry
- WRAP Ordnance And Accessories
- CTSO Medical/Dental Instruments
- Sector
- WRAP Industrials
- CTSO Health Care
- Exchange
- WRAP Nasdaq
- CTSO Nasdaq
- Market Cap
- WRAP 74.7M
- CTSO 68.2M
- IPO Year
- WRAP N/A
- CTSO N/A
- Fundamental
- Price
- WRAP $1.44
- CTSO $0.85
- Analyst Decision
- WRAP
- CTSO Buy
- Analyst Count
- WRAP 0
- CTSO 2
- Target Price
- WRAP N/A
- CTSO $5.50
- AVG Volume (30 Days)
- WRAP 124.8K
- CTSO 149.4K
- Earning Date
- WRAP 05-15-2025
- CTSO 05-14-2025
- Dividend Yield
- WRAP N/A
- CTSO N/A
- EPS Growth
- WRAP N/A
- CTSO N/A
- EPS
- WRAP N/A
- CTSO N/A
- Revenue
- WRAP $3,796,000.00
- CTSO $35,332,238.00
- Revenue This Year
- WRAP N/A
- CTSO $18.72
- Revenue Next Year
- WRAP N/A
- CTSO $19.75
- P/E Ratio
- WRAP N/A
- CTSO N/A
- Revenue Growth
- WRAP N/A
- CTSO 15.37
- 52 Week Low
- WRAP $1.21
- CTSO $0.70
- 52 Week High
- WRAP $2.58
- CTSO $1.61
- Technical
- Relative Strength Index (RSI)
- WRAP 44.91
- CTSO 42.92
- Support Level
- WRAP $1.30
- CTSO $0.81
- Resistance Level
- WRAP $1.50
- CTSO $0.90
- Average True Range (ATR)
- WRAP 0.09
- CTSO 0.06
- MACD
- WRAP 0.01
- CTSO 0.00
- Stochastic Oscillator
- WRAP 48.21
- CTSO 38.91
About WRAP Wrap Technologies Inc.
Wrap Technologies Inc is a public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel worldwide. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.